Related Experiment Video
Updated: Jul 10, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study
Michelle C Odden1, Rebecca Scherzer, Peter Bacchetti
1Department of Medicine, San FranciscoVeterans Affairs Medical Center 4150 Clement Street, San Francisco, CA 94121, USA.
Insights
Human immunodeficiency virus (HIV) infection is linked to worse kidney function, as indicated by elevated cystatin C levels. This marker may help identify HIV patients at higher risk for kidney and cardiovascular diseases.
Area of Science:
- Nephrology
- Infectious Diseases
- Biomarkers
Background:
- Studies indicate a high prevalence of end-stage renal disease in individuals with human immunodeficiency virus (HIV).
- Moderate kidney function impairments in HIV-infected persons are less understood.
- Cystatin C may be a more sensitive marker than creatinine for detecting kidney dysfunction in HIV patients.
Purpose of the Study:
- To evaluate kidney function in HIV-infected individuals using cystatin C and creatinine.
- To compare kidney function markers between HIV-infected persons and controls.
Main Methods:
- Kidney function was assessed in 1008 HIV-infected individuals and 290 controls from the FRAM and CARDIA studies.
- Cystatin C and creatinine levels were measured.
- Estimated glomerular filtration rates (eGFR) were calculated.
Main Results:
- HIV-infected individuals had significantly higher mean cystatin C levels (0.92 +/- 0.22 mg/L) compared to controls (0.76 +/- 0.15 mg/L).
- Mean creatinine levels and eGFR were similar between HIV-infected individuals and controls.
- HIV-infected individuals were more likely to have cystatin C levels >1.0 mg/L, a threshold associated with increased mortality and disease risk.
Conclusions:
- HIV infection is associated with substantially worse kidney function when measured by cystatin C, despite similar creatinine-based measures.
- Cystatin C measurement can identify HIV-infected individuals at increased risk for kidney and cardiovascular diseases.
- Factors like hypertension, low HDL, HCV coinfection, and lower CD4 count were associated with higher cystatin C levels in HIV patients.
Background:
Although studies have reported a high prevalence of end-stage renal disease in human immunodeficiency virus (HIV)-infected individuals, little is known about moderate impairments in kidney function. Cystatin C measurement may be more sensitive than creatinine for detecting impaired kidney function in persons with HIV.
Methods:
We evaluated kidney function in the Fat Redistribution and Metabolic Change in HIV Infection (FRAM) cohort, a representative sample of 1008 HIV-infected persons and 290 controls from the Coronary Artery Risk Development in Young Adults (CARDIA) study in the United States.
Results:
Cystatin C level was elevated in HIV-infected individuals; the mean +/- SD cystatin C level was 0.92 +/- 0.22 mg/L in those infected with HIV and 0.76 +/- 0.15 mg/L in controls (P < .001). In contrast, both mean creatinine levels and estimated glomerular filtration rates appeared similar in HIV-infected individuals and controls (0.87 +/- 0.21 vs 0.85 +/- 0.19 mg/dL [to convert to micromoles per liter, multiply by 88.4] [P = .35] and 110 +/- 26 vs 106 +/- 23 mL/min/1.73 m(2) [P = .06], respectively). Persons with HIV infection were more likely to have a cystatin C level greater than 1.0 mg/L (OR, 9.8; 95% confidence interval, 4.4-22.0 [P <.001]), a threshold demonstrated to be associated with increased risk for death and cardiovascular and kidney disease. Among participants with HIV, potentially modifiable risk factors for kidney disease, hypertension, and low high-density lipoprotein concentration were associated with a higher cystatin C level, as were lower CD4 lymphocyte count and coinfection with hepatitis C virus (all P < .001).
Conclusions:
Individuals infected with HIV had substantially worse kidney function when measured by cystatin C level compared with HIV-negative controls, whereas mean creatinine levels and estimated glomerular filtration rates were similar. Cystatin C measurement could be a useful clinical tool to identify HIV-infected persons at increased risk for kidney and cardiovascular disease.
Related Concept Videos
Serum Studies: Renal Function Tests
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

